NVO - Novo Nordisk A/S

Industry: Drug Manufacturers - Other Sector: Healthcare Exchange: NYSE

Fri 20'th Jul 2018

PERIOD 2018-04-23 - 2018-07-20
CHANGE 1.26%
PRICE $50.44
VOLUME
Buy
TREND
Hold

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Request Prediction
0.00%
Predict

Novo Nordisk A/S Stock Analysis

Technical stock analysis for Fri 20'th Jul 2018

Buy candidate since 2018-07-20
Shorts 1.11% ( 2018-06-29 )
Cash 9 335.2 mill
Loans n/a
Beta 0.66
ROA 41.25

Novo Nordisk A/S gained 1.26% in the last trading day, rising from $49.81 to $50.44 The price has risen in 6 of the last 10 days and is up by 4.19% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.07 million more shares were traded than the day before. In total, 1.38 million shares bought and sold for approximately $69.55 million.

Trend

Novo Nordisk A/S has broken the wide and horizontal trend up. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately. $50.23 is considered to be a "second chance" to hit a potential runner. It is, however, important that volume does follow the price as false breaks may appear and it may move back into the horizontal trend. Based on the rectangle-formation theory the stock is predicted to reach $56.03 sometime during the next 3 months.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Novo Nordisk A/S holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $49.99 and $47.11. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday June 27, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 80 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $46.97 and $46.80.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novo Nordisk A/S finds support just below today's level at $46.97. If this is broken, then the next support from accumulated volume will be at $46.80 and $44.93.

Support: $46.97 Price: $50.44

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.52 (1.04%) between high and low. For the last week, the stock has had a daily average volatility of 0.91%.

The stock is extremely overbought on RSI14 (80). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stoploss: $47.95 (-4.94%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 80 and this increases the risk substantially. There is a buy signal from pivot bottom found 16 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals are positive and the stock has broken the horizontal trend up, which indicates an even stronger rising rate. We conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term period. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.

Buy Candidate

Click for Top 5 Buy Candidates
NVO $50.44 $0.63(1.26%)
NVO is up $0.63 today, but where's it headed in August?
Zacks Investment Research is releasing its prediction for NVO based on the 1-3 month system that more than doubles the S&P 500.

Click here – the NVO analysis is free »
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL